Skip to main content
No access
Articles
Published Online: 4 October 2023

Inequalities in the Incidence of Psychotic Disorders Among Racial and Ethnic Groups

Publication: American Journal of Psychiatry

Abstract

Objective:

The authors examined recent trends in incidence of psychotic disorders, demographic characteristics, and comorbid psychiatric and medical conditions among six racial/ethnic groups.

Method:

A retrospective cohort study design was used to examine the incidence of psychotic disorders across race/ethnicity groups and comorbid psychiatric and medical conditions among members of Kaiser Permanente Northern California from 2009 to 2019 (N=5,994,758). Poisson regression was used to assess changes in annual incidence, and Cox proportional hazards and logistic regression models adjusted for age and sex were used to test correlates and consequences.

Results:

Overall, the incidence of nonaffective psychotic disorders decreased slightly over the study period. Compared with White members, the risk of nonaffective psychosis diagnosis was higher among Black (hazard ratio=2.13, 95% CI=2.02–2.24) and American Indian or Alaskan Native (AIAN) (hazard ratio=1.85, 95% CI=1.53–2.23) members and lower among Asian (hazard ratio=0.72, 95% CI=0.68–0.76) and Hispanic (hazard ratio=0.91, 95% CI=0.87–0.96) members, as well as those whose race/ethnicity was categorized as “other” (hazard ratio=0.92, 95% CI=0.86–0.99). Compared with White members, the risk of affective psychosis diagnosis adjusted for age and sex was higher among Black (hazard ratio=1.76, 95% CI=1.62–1.91), Hispanic (hazard ratio=1.09, 95% CI=1.02–1.16), and AIAN (hazard ratio=1.38, 95% CI=1.00–1.90) members and lower among Asian (hazard ratio=0.77, 95% CI=0.71–0.83), Native Hawaiian or other Pacific Islander (hazard ratio=0.69, 95% CI=0.48–0.99), and “other” (hazard ratio=0.86, 95% CI=0.77–0.96) members. Psychotic disorders were associated with significantly higher odds of suicide (odds ratio=2.65, 95% CI=2.15–3.28), premature death (odds ratio=1.30, 95% CI=1.22–1.39), and stroke (odds ratio=1.64, 95% CI=1.55–1.72) and lower odds of health care utilization (odds ratio=0.44, 95% CI=0.42–0.47).

Conclusions:

This study demonstrates racial and ethnic variation in incident psychotic disorder diagnoses in the United States, compared with non-Hispanic Whites. Individuals diagnosed with psychosis face a greater burden of other negative health outcomes and lower odds of health care utilization, reflecting personal and economic impacts. Identifying risk factors for elevated rates and protective influences in subgroups can inform strategies for prevention and interventions to ameliorate severe consequences of psychotic syndromes.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 805 - 814
PubMed: 37789743

History

Received: 4 November 2022
Revision received: 3 May 2023
Accepted: 31 May 2023
Published online: 4 October 2023
Published in print: November 1, 2023

Keywords

  1. Affective Psychosis
  2. Disparities
  3. Epidemiology
  4. Mental Health
  5. Nonaffective Psychosis
  6. Treated Incidence

Authors

Affiliations

Winston Chung, M.D. [email protected]
Department of Psychiatry, Kaiser Permanente Northern California, San Francisco (Chung); Division of Research, Kaiser Permanente Northern California, Oakland (Jiang); Center for the Developing Brain, Child Mind Institute, New York (Milham); Center for Biomedical Imaging and Neuromodulation, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y. (Milham); Genetic Epidemiology Research Branch, NIMH, Bethesda, Md. (Merikangas, Paksarian).
Sheng-Fang Jiang, M.S.
Department of Psychiatry, Kaiser Permanente Northern California, San Francisco (Chung); Division of Research, Kaiser Permanente Northern California, Oakland (Jiang); Center for the Developing Brain, Child Mind Institute, New York (Milham); Center for Biomedical Imaging and Neuromodulation, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y. (Milham); Genetic Epidemiology Research Branch, NIMH, Bethesda, Md. (Merikangas, Paksarian).
Michael P. Milham, M.D., Ph.D.
Department of Psychiatry, Kaiser Permanente Northern California, San Francisco (Chung); Division of Research, Kaiser Permanente Northern California, Oakland (Jiang); Center for the Developing Brain, Child Mind Institute, New York (Milham); Center for Biomedical Imaging and Neuromodulation, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y. (Milham); Genetic Epidemiology Research Branch, NIMH, Bethesda, Md. (Merikangas, Paksarian).
Kathleen R. Merikangas, Ph.D.
Department of Psychiatry, Kaiser Permanente Northern California, San Francisco (Chung); Division of Research, Kaiser Permanente Northern California, Oakland (Jiang); Center for the Developing Brain, Child Mind Institute, New York (Milham); Center for Biomedical Imaging and Neuromodulation, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y. (Milham); Genetic Epidemiology Research Branch, NIMH, Bethesda, Md. (Merikangas, Paksarian).
Diana Paksarian, M.P.H., Ph.D.
Department of Psychiatry, Kaiser Permanente Northern California, San Francisco (Chung); Division of Research, Kaiser Permanente Northern California, Oakland (Jiang); Center for the Developing Brain, Child Mind Institute, New York (Milham); Center for Biomedical Imaging and Neuromodulation, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y. (Milham); Genetic Epidemiology Research Branch, NIMH, Bethesda, Md. (Merikangas, Paksarian).

Notes

Send correspondence to Dr. Chung ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

This study was supported by a grant from the Kaiser Permanente Northern California Community Benefit Program. The work by Dr. Merikangas and Dr. Paksarian was supported by the Intramural Research Program of NIMH. The work by Dr. Milham was supported by gifts to the Child Mind Institute from Phyllis Green, Randolph Cowen, and Joseph Healey and funding from NIH (U01MH099059).The views and opinions in this article are those of the authors and should not be construed to represent the views of the sponsoring organizations or agencies or the U.S. government.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share